**Question:** Regarding lamotrigine, which of the following is a TRUE statement?

A. Lamotrigine is an anticonvulsant drug
B. Lamotrigine decreases the excitatory neurotransmission
C. Lamotrigine primarily affects GABA neurotransmission
D. Lamotrigine is primarily used as a mood stabilizer

**Core Concept:**
Lamotrigine is a medication that belongs to the class of antiepileptic drugs (AEDs) and is primarily used in the treatment of epilepsy and bipolar disorder. It is a rationally designed antiepileptic drug, meaning it was developed based on a rational understanding of its mechanism of action.

**Why the Correct Answer is Right:**
Lamotrigine is a true anticonvulsant drug, working primarily by decreasing the excitatory neurotransmission. It achieves this by inhibiting the enzyme L-glutamate carboxypeptidase, which is involved in the degradation of the excitatory neurotransmitter L-glutamate. By inhibiting this enzyme, lamotrigine leads to a decrease in L-glutamate levels, thereby reducing the excitatory neurotransmission and providing its anticonvulsant effect.

**Why Each Wrong Option is Incorrect:**

A. Lamotrigine primarily affects GABA neurotransmission (Option C):
While lamotrigine does not primarily interact with GABA (gamma-aminobutyric acid), it does have some effects on GABA neurotransmission. However, its primary mechanism is not GABA-related, making Option C false.

B. Lamotrigine is primarily used as a mood stabilizer (Option B):
While lamotrigine is used in the treatment of bipolar disorder, its primary indication is epilepsy, not mood stabilization. This makes Option B false.

C. Lamotrigine is an anticonvulsant drug (Option A):
As explained earlier, lamotrigine is indeed an anticonvulsant drug, making this statement true.

D. Lamotrigine is a mood stabilizer (Option D):
As explained above, lamotrigine is primarily used in the treatment of epilepsy, not mood stabilization. This makes Option D false.

**Clinical Pearl:**
Lamotrigine is a well-tolerated antiepileptic drug with a good safety profile. It is used in combination with other antiepileptic drugs or as monotherapy in the treatment of various types of epilepsy, including partial seizures, generalized tonic-clonic seizures, and primary generalized tonic seizures. Its use in mood stabilization is a secondary indication.